Global Alprostadil Injection Production, Demand and Key Producers, 2022-2028

November 2022 | 115 pages | ID: G417CA9BA9C6EN
GlobalInfoResearch

US$ 4,480.00

E-mail Delivery (PDF)

Download PDF Leaflet

Accepted cards
Wire Transfer
Checkout Later
Need Help? Ask a Question
A prostaglandin

This report studies the global Alprostadil Injection production, demand, key manufacturers, and key regions.

This report is a detailed and comprehensive analysis of the world market for Alprostadil Injection, and provides market size (US$ million) and Year-over-Year (YoY) Growth, considering 2021 as the base year. This report explores demand trends and competition, as well as details the characteristics of Alprostadil Injection that contribute to its increasing demand across many markets.

The global Alprostadil Injection market size is expected to reach $ million by 2028, rising at a market growth of % CAGR during the forecast period (2022-2028).

Highlights and key features of the study

Global Alprostadil Injection total production and demand, 2017-2028, (Vial)

Global Alprostadil Injection total production value, 2017-2028, (USD Million)

Global Alprostadil Injection production by region & country, production, value, CAGR, 2017-2028, (USD Million) & (Vial)

Global Alprostadil Injection consumption by region & country, CAGR, 2017-2028 & (Vial)

U.S. VS China: Alprostadil Injection domestic production, consumption, key domestic manufacturers and share

Global Alprostadil Injection production by manufacturer, production, price, value and market share 2017-2022, (USD Million) & (Vial)

Global Alprostadil Injection production by Dosage Strength, production, value, CAGR, 2017-2028, (USD Million) & (Vial)

Global Alprostadil Injection production by Application production, value, CAGR, 2017-2028, (USD Million) & (Vial)

This reports profiles key players in the global Alprostadil Injection market based on the following parameters – headquarters, production locations, products portfolio, Alprostadil Injection revenue, sales, average price and gross margin, recent developments.

This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the World Alprostadil Injection market

Detailed Segmentation:

Each section contains quantitative market data including market by value (US$ Millions), volume (production, consumption) & (Vial) and average price (US$/Vial) by manufacturer, by Dosage Strength, and by Application. Data is given for the years 2017-2028 by year with 2021 as the base year, 2022 as the estimate year, and 2028 as the forecast year.

Global Alprostadil Injection Market, By Region:
  • United States
  • China
  • Europe
  • Japan
  • South Korea
  • ASEAN
  • India
Global Alprostadil Injection Market, Segmentation by Dosage Strength
  • 0.5Mg/Ml
  • 1Mg/Ml
  • 2Mg/Ml
  • Other
Global Alprostadil Injection Market, Segmentation by Application
  • Myocardial Infarction
  • Thrombotic Vasculitis
  • Occlusive Arteriosclerosis
  • Other
Companies Profiled:
  • Louston
  • CP Group
  • Yinglian Biopharmaceutical
  • Green Biology
  • HPGC
  • Swiss Parenterals
  • Endo Pharm
  • Ferring Pharmaceuticals
  • Hikma Pharmaceuticals
  • Lifespan Biotech
  • Viatris
  • Orifarm Group
  • Pfizer
  • Sandoz
  • Teva Pharmaceutical
Key Questions Answered

1. How big is the global Alprostadil Injection market?

2. What is the demand of the global Alprostadil Injection market?

3. What is the year over year growth of the global Alprostadil Injection market?

4. What is the production and production value of the global Alprostadil Injection market?

5. Who are the key producers in the global Alprostadil Injection market?

6. What are the growth factors driving the market demand?
1 SUPPLY SUMMARY

1.1 Alprostadil Injection Introduction
1.2 World Alprostadil Injection Supply & Forecast
  1.2.1 World Alprostadil Injection Production Value (2017 & 2021 & 2028)
  1.2.2 World Alprostadil Injection Production (2017-2028)
  1.2.3 World Alprostadil Injection Pricing Trends (2017-2028)
1.3 World Alprostadil Injection Production by Region
  1.3.1 World Alprostadil Injection Production Value by Region (2017-2028)
  1.3.2 World Alprostadil Injection Production by Region (2017-2028)
  1.3.3 World Alprostadil Injection Average Price by Region (2017-2028)
  1.3.4 North America Alprostadil Injection Production (2017-2028)
  1.3.5 Europe Alprostadil Injection Production (2017-2028)
  1.3.6 China Alprostadil Injection Production (2017-2028)
  1.3.7 Japan Alprostadil Injection Production (2017-2028)
1.4 Market Drivers, Restraints and Trends
  1.4.1 Alprostadil Injection Market Drivers
  1.4.2 Factors Affecting Demand
  1.4.3 Alprostadil Injection Major Market Trends
1.5 Influence of COVID-19 and Russia-Ukraine War
  1.5.1 Influence of COVID-19
  1.5.2 Influence of Russia-Ukraine War

2 DEMAND SUMMARY

2.1 World Alprostadil Injection Demand (2017-2028)
2.2 World Alprostadil Injection Consumption by Region
  2.2.1 World Alprostadil Injection Consumption by Region (2017-2022)
  2.2.2 World Alprostadil Injection Consumption Forecast by Region (2023-2028)
2.3 United States Alprostadil Injection Consumption (2017-2028)
2.4 China Alprostadil Injection Consumption (2017-2028)
2.5 Europe Alprostadil Injection Consumption (2017-2028)
2.6 Japan Alprostadil Injection Consumption (2017-2028)
2.7 South Korea Alprostadil Injection Consumption (2017-2028)
2.8 ASEAN Alprostadil Injection Consumption (2017-2028)
2.9 India Alprostadil Injection Consumption (2017-2028)

3 WORLD ALPROSTADIL INJECTION MANUFACTURERS COMPETITIVE ANALYSIS

3.1 World Alprostadil Injection Production Value by Manufacturer (2017-2022)
3.2 World Alprostadil Injection Production by Manufacturer (2017-2022)
3.3 World Alprostadil Injection Average Price by Manufacturer (2017-2022)
3.4 Alprostadil Injection Company Evaluation Quadrant
3.5 Industry Rank and Concentration Rate (CR)
  3.5.1 Global Alprostadil Injection Industry Rank of Major Manufacturers
  3.5.2 Global Concentration Ratios (CR4) for Alprostadil Injection in 2021
  3.5.3 Global Concentration Ratios (CR8) for Alprostadil Injection in 2021
3.6 Alprostadil Injection Market: Overall Company Footprint Analysis
  3.6.1 Alprostadil Injection Market: Region Footprint
  3.6.2 Alprostadil Injection Market: Company Product Type Footprint
  3.6.3 Alprostadil Injection Market: Company Product Application Footprint
3.7 Competitive Environment
  3.7.1 Historical Structure of the Industry
  3.7.2 Barriers of Market Entry
  3.7.3 Factors of Competition
3.8 New Entrant and Capacity Expansion Plans
3.9 Mergers, Acquisition, Agreements, and Collaborations

4 UNITED STATES VS CHINA VS REST OF THE WORLD

4.1 United States VS China: Alprostadil Injection Production Value Comparison
  4.1.1 United States VS China: Alprostadil Injection Production Value Comparison (2017 & 2021 & 2028)
  4.1.2 United States VS China: Alprostadil Injection Production Value Market Share Comparison (2017 & 2021 & 2028)
4.2 United States VS China: Alprostadil Injection Production Comparison
  4.2.1 United States VS China: Alprostadil Injection Production Comparison (2017 & 2021 & 2028)
  4.2.2 United States VS China: Alprostadil Injection Production Market Share Comparison (2017 & 2021 & 2028)
4.3 United States VS China: Alprostadil Injection Consumption Comparison
  4.3.1 United States VS China: Alprostadil Injection Consumption Comparison (2017 & 2021 & 2028)
  4.3.2 United States VS China: Alprostadil Injection Consumption Market Share Comparison (2017 & 2021 & 2028)
4.4 United States Alprostadil Injection Key Producers and Market Share, 2017-2022
  4.4.1 Major Manufacturer of Alprostadil Injection in United States, Company Headquarters and Production Place (States, Country)
  4.4.2 United States Alprostadil Injection Production Value by Domestic Manufacturer, (2017-2022)
  4.4.3 United States Alprostadil Injection Production by Domestic Manufacturer, (2017-2022)
4.5 China Alprostadil Injection Key Producers and Market Share, 2017-2022
  4.5.1 Major Manufacturer of Alprostadil Injection in China, Company Headquarters and Production Place (Province, Country)
  4.5.2 China Alprostadil Injection Production Value by Domestic Manufacturer, (2017-2022)
  4.5.3 China Alprostadil Injection Production by Domestic Manufacturer, (2017-2022)
4.6 Rest of World Alprostadil Injection Key Producers and Market Share, 2017-2022
  4.6.1 Major Manufacturer of Alprostadil Injection in Rest of World, Company Headquarters and Production Place (State, Country)
  4.6.2 Rest of World Alprostadil Injection Production Value by Domestic Manufacturer, (2017-2022)
  4.6.3 Rest of World Alprostadil Injection Production by Domestic Manufacturer, (2017-2022)

5 MARKET ANALYSIS BY DOSAGE STRENGTH

5.1 World Alprostadil Injection Market Size Overview by Dosage Strength: 2017 VS 2021 VS 2028
5.2 Segment Introduction by Dosage Strength
  5.2.1 0.5Mg/Ml
  5.2.2 1Mg/Ml
  5.2.3 2Mg/Ml
  5.2.4 Other
5.3 Market Segment by Dosage Strength
  5.3.1 World Alprostadil Injection Production by Dosage Strength (2017-2028)
  5.3.2 World Alprostadil Injection Production Value by Dosage Strength (2017-2028)
  5.3.3 World Alprostadil Injection Average Price by Dosage Strength (2017-2028)

6 MARKET ANALYSIS BY APPLICATION

6.1 World Alprostadil Injection Market Size Overview by Application: 2017 VS 2021 VS 2028
6.2 Segment Introduction by Application
  6.2.1 Myocardial Infarction
  6.2.2 Thrombotic Vasculitis
  6.2.3 Occlusive Arteriosclerosis
  6.2.4 Other
6.3 Market Segment by Application
  6.3.1 World Alprostadil Injection Production by Application (2017-2028)
  6.3.2 World Alprostadil Injection Production Value by Application (2017-2028)
  6.3.3 World Alprostadil Injection Average Price by Application (2017-2028)

7 COMPANY PROFILES

7.1 Louston
  7.1.1 Louston Details
  7.1.2 Louston Major Business
  7.1.3 Louston Alprostadil Injection Product and Services
  7.1.4 Louston Alprostadil Injection Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.1.5 Louston Recent Developments/Updates
  7.1.6 Louston Competitive Strengths & Weaknesses
7.2 CP Group
  7.2.1 CP Group Details
  7.2.2 CP Group Major Business
  7.2.3 CP Group Alprostadil Injection Product and Services
  7.2.4 CP Group Alprostadil Injection Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.2.5 CP Group Recent Developments/Updates
  7.2.6 CP Group Competitive Strengths & Weaknesses
7.3 Yinglian Biopharmaceutical
  7.3.1 Yinglian Biopharmaceutical Details
  7.3.2 Yinglian Biopharmaceutical Major Business
  7.3.3 Yinglian Biopharmaceutical Alprostadil Injection Product and Services
  7.3.4 Yinglian Biopharmaceutical Alprostadil Injection Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.3.5 Yinglian Biopharmaceutical Recent Developments/Updates
  7.3.6 Yinglian Biopharmaceutical Competitive Strengths & Weaknesses
7.4 Green Biology
  7.4.1 Green Biology Details
  7.4.2 Green Biology Major Business
  7.4.3 Green Biology Alprostadil Injection Product and Services
  7.4.4 Green Biology Alprostadil Injection Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.4.5 Green Biology Recent Developments/Updates
  7.4.6 Green Biology Competitive Strengths & Weaknesses
7.5 HPGC
  7.5.1 HPGC Details
  7.5.2 HPGC Major Business
  7.5.3 HPGC Alprostadil Injection Product and Services
  7.5.4 HPGC Alprostadil Injection Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.5.5 HPGC Recent Developments/Updates
  7.5.6 HPGC Competitive Strengths & Weaknesses
7.6 Swiss Parenterals
  7.6.1 Swiss Parenterals Details
  7.6.2 Swiss Parenterals Major Business
  7.6.3 Swiss Parenterals Alprostadil Injection Product and Services
  7.6.4 Swiss Parenterals Alprostadil Injection Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.6.5 Swiss Parenterals Recent Developments/Updates
  7.6.6 Swiss Parenterals Competitive Strengths & Weaknesses
7.7 Endo Pharm
  7.7.1 Endo Pharm Details
  7.7.2 Endo Pharm Major Business
  7.7.3 Endo Pharm Alprostadil Injection Product and Services
  7.7.4 Endo Pharm Alprostadil Injection Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.7.5 Endo Pharm Recent Developments/Updates
  7.7.6 Endo Pharm Competitive Strengths & Weaknesses
7.8 Ferring Pharmaceuticals
  7.8.1 Ferring Pharmaceuticals Details
  7.8.2 Ferring Pharmaceuticals Major Business
  7.8.3 Ferring Pharmaceuticals Alprostadil Injection Product and Services
  7.8.4 Ferring Pharmaceuticals Alprostadil Injection Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.8.5 Ferring Pharmaceuticals Recent Developments/Updates
  7.8.6 Ferring Pharmaceuticals Competitive Strengths & Weaknesses
7.9 Hikma Pharmaceuticals
  7.9.1 Hikma Pharmaceuticals Details
  7.9.2 Hikma Pharmaceuticals Major Business
  7.9.3 Hikma Pharmaceuticals Alprostadil Injection Product and Services
  7.9.4 Hikma Pharmaceuticals Alprostadil Injection Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.9.5 Hikma Pharmaceuticals Recent Developments/Updates
  7.9.6 Hikma Pharmaceuticals Competitive Strengths & Weaknesses
7.10 Lifespan Biotech
  7.10.1 Lifespan Biotech Details
  7.10.2 Lifespan Biotech Major Business
  7.10.3 Lifespan Biotech Alprostadil Injection Product and Services
  7.10.4 Lifespan Biotech Alprostadil Injection Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.10.5 Lifespan Biotech Recent Developments/Updates
  7.10.6 Lifespan Biotech Competitive Strengths & Weaknesses
7.11 Viatris
  7.11.1 Viatris Details
  7.11.2 Viatris Major Business
  7.11.3 Viatris Alprostadil Injection Product and Services
  7.11.4 Viatris Alprostadil Injection Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.11.5 Viatris Recent Developments/Updates
  7.11.6 Viatris Competitive Strengths & Weaknesses
7.12 Orifarm Group
  7.12.1 Orifarm Group Details
  7.12.2 Orifarm Group Major Business
  7.12.3 Orifarm Group Alprostadil Injection Product and Services
  7.12.4 Orifarm Group Alprostadil Injection Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.12.5 Orifarm Group Recent Developments/Updates
  7.12.6 Orifarm Group Competitive Strengths & Weaknesses
7.13 Pfizer
  7.13.1 Pfizer Details
  7.13.2 Pfizer Major Business
  7.13.3 Pfizer Alprostadil Injection Product and Services
  7.13.4 Pfizer Alprostadil Injection Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.13.5 Pfizer Recent Developments/Updates
  7.13.6 Pfizer Competitive Strengths & Weaknesses
7.14 Sandoz
  7.14.1 Sandoz Details
  7.14.2 Sandoz Major Business
  7.14.3 Sandoz Alprostadil Injection Product and Services
  7.14.4 Sandoz Alprostadil Injection Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.14.5 Sandoz Recent Developments/Updates
  7.14.6 Sandoz Competitive Strengths & Weaknesses
7.15 Teva Pharmaceutical
  7.15.1 Teva Pharmaceutical Details
  7.15.2 Teva Pharmaceutical Major Business
  7.15.3 Teva Pharmaceutical Alprostadil Injection Product and Services
  7.15.4 Teva Pharmaceutical Alprostadil Injection Production, Price, Value, Gross Margin and Market Share (2017-2022)
  7.15.5 Teva Pharmaceutical Recent Developments/Updates
  7.15.6 Teva Pharmaceutical Competitive Strengths & Weaknesses

8 RAW MATERIAL AND INDUSTRY CHAIN

8.1 Raw Material of Alprostadil Injection and Key Manufacturers
8.2 Alprostadil Injection Manufacturing Costs
8.3 Alprostadil Injection Production Process
8.4 Alprostadil Injection Industrial Chain

9 DISTRIBUTION CHANNEL ANALYSIS

9.1 Distribution Channel Breakdown for Alprostadil Injection Shipments (%): 2017-2028
  9.1.1 Direct Channel
  9.1.2 Indirect Channel
9.2 Alprostadil Injection Typical Distributors
9.3 Alprostadil Injection Typical Customers

10 RESEARCH FINDINGS AND CONCLUSION

11 APPENDIX

11.1 Methodology
11.2 Research Process and Data Source
11.3 Disclaimer

LIST OF TABLES

Table 1. World Alprostadil Injection Production Value by Region (2017, 2022 and 2028) & (USD Million)
Table 2. World Alprostadil Injection Production Value by Region (2017-2022) & (USD Million)
Table 3. World Alprostadil Injection Production Value by Region (2023-2028) & (USD Million)
Table 4. World Alprostadil Injection Production Value Market Share by Region (2017-2022)
Table 5. World Alprostadil Injection Production Value Market Share by Region (2023-2028)
Table 6. World Alprostadil Injection Production by Region (2017-2022) & (Vial)
Table 7. World Alprostadil Injection Production by Region (2023-2028) & (Vial)
Table 8. World Alprostadil Injection Production Market Share by Region (2017-2022)
Table 9. World Alprostadil Injection Production Market Share by Region (2023-2028)
Table 10. World Alprostadil Injection Average Price by Region (2017-2022) & (US$/Vial)
Table 11. World Alprostadil Injection Average Price by Region (2023-2028) & (US$/Vial)
Table 12. Alprostadil Injection Major Market Trends
Table 13. World Alprostadil Injection Consumption Growth Rate Forecast by Region (2017 & 2021 & 2028) & (Vial)
Table 14. World Alprostadil Injection Consumption by Region (2017-2022) & (Vial)
Table 15. World Alprostadil Injection Consumption Forecast by Region (2023-2028) & (Vial)
Table 16. World Alprostadil Injection Production Value by Manufacturer (2017-2022) & (USD Million)
Table 17. Production Value Market Share of Key Alprostadil Injection Producers in 2021
Table 18. World Alprostadil Injection Production by Manufacturer (2017-2022) & (Vial)
Table 19. Production Market Share of Key Alprostadil Injection Producers in 2021
Table 20. World Alprostadil Injection Average Price by Manufacturer (2017-2022) & (US$/Vial)
Table 21. Global Alprostadil Injection Company Evaluation Quadrant
Table 22. World Alprostadil Injection Industry Rank of Major Manufacturers, Based on Production Value in 2021
Table 23. Head Office and Alprostadil Injection Production Site of Key Manufacturer
Table 24. Alprostadil Injection Market: Company Product Type Footprint
Table 25. Alprostadil Injection Market: Company Product Application Footprint
Table 26. Alprostadil Injection Competitive Factors
Table 27. Alprostadil Injection New Entrant and Capacity Expansion Plans
Table 28. Alprostadil Injection Mergers & Acquisitions Activity
Table 29. United States VS China Alprostadil Injection Production Value Comparison, (2017 & 2021 & 2028) & (USD Million)
Table 30. United States VS China Alprostadil Injection Production Comparison, (2017 & 2021 & 2028) & (Vial)
Table 31. United States VS China Alprostadil Injection Consumption Comparison, (2017 & 2021 & 2028) & (Vial)
Table 32. Major Manufacturer of Alprostadil Injection in United States, Company Headquarters and Production Place (States, Country)
Table 33. United States Alprostadil Injection Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 34. United States Alprostadil Injection Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 35. United States Alprostadil Injection Production by Domestic Manufacturer, (2017-2022) & (Vial)
Table 36. United States Alprostadil Injection Production Market Share by Domestic Manufacturer, (2017-2022)
Table 37. Major Manufacturer of Alprostadil Injection in China, Company Headquarters and Production Place (Province, Country)
Table 38. China Alprostadil Injection Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 39. China Alprostadil Injection Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 40. China Alprostadil Injection Production by Domestic Manufacturer, (2017-2022) & (Vial)
Table 41. China Alprostadil Injection Production Market Share by Domestic Manufacturer, (2017-2022)
Table 42. Major Manufacturer of Alprostadil Injection in Rest of World, Company Headquarters and Production Place (State, Country)
Table 43. Rest of World Alprostadil Injection Production Value by Domestic Manufacturer, (2017-2022) & (USD Million)
Table 44. Rest of World Alprostadil Injection Production Value Market Share by Domestic Manufacturer, (2017-2022)
Table 45. Rest of World Alprostadil Injection Production by Domestic Manufacturer, (2017-2022) & (Vial)
Table 46. Rest of World Alprostadil Injection Production Market Share by Domestic Manufacturer, (2017-2022)
Table 47. World Alprostadil Injection Production Value by Dosage Strength, (USD Million), 2017 & 2021 & 2028
Table 48. World Alprostadil Injection Production by Dosage Strength (2017-2022) & (Vial)
Table 49. World Alprostadil Injection Production by Dosage Strength (2023-2028) & (Vial)
Table 50. World Alprostadil Injection Production Value by Dosage Strength (2017-2022) & (USD Million)
Table 51. World Alprostadil Injection Production Value by Dosage Strength (2023-2028) & (USD Million)
Table 52. World Alprostadil Injection Average Price by Dosage Strength (2017-2022) & (US$/Vial)
Table 53. World Alprostadil Injection Average Price by Dosage Strength (2023-2028) & (US$/Vial)
Table 54. World Alprostadil Injection Production Value by Application, (USD Million), 2017 & 2021 & 2028
Table 55. World Alprostadil Injection Production by Application (2017-2022) & (Vial)
Table 56. World Alprostadil Injection Production by Application (2023-2028) & (Vial)
Table 57. World Alprostadil Injection Production Value by Application (2017-2022) & (USD Million)
Table 58. World Alprostadil Injection Production Value by Application (2023-2028) & (USD Million)
Table 59. World Alprostadil Injection Average Price by Application (2017-2022) & (US$/Vial)
Table 60. World Alprostadil Injection Average Price by Application (2023-2028) & (US$/Vial)
Table 61. Louston Basic Information, Manufacturing Base and Competitors
Table 62. Louston Major Business
Table 63. Louston Alprostadil Injection Product and Services
Table 64. Louston Alprostadil Injection Production (Vial), Price (US$/Vial), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 65. Louston Recent Developments/Updates
Table 66. Louston Competitive Strengths & Weaknesses
Table 67. CP Group Basic Information, Manufacturing Base and Competitors
Table 68. CP Group Major Business
Table 69. CP Group Alprostadil Injection Product and Services
Table 70. CP Group Alprostadil Injection Production (Vial), Price (US$/Vial), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 71. CP Group Recent Developments/Updates
Table 72. CP Group Competitive Strengths & Weaknesses
Table 73. Yinglian Biopharmaceutical Basic Information, Manufacturing Base and Competitors
Table 74. Yinglian Biopharmaceutical Major Business
Table 75. Yinglian Biopharmaceutical Alprostadil Injection Product and Services
Table 76. Yinglian Biopharmaceutical Alprostadil Injection Production (Vial), Price (US$/Vial), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 77. Yinglian Biopharmaceutical Recent Developments/Updates
Table 78. Yinglian Biopharmaceutical Competitive Strengths & Weaknesses
Table 79. Green Biology Basic Information, Manufacturing Base and Competitors
Table 80. Green Biology Major Business
Table 81. Green Biology Alprostadil Injection Product and Services
Table 82. Green Biology Alprostadil Injection Production (Vial), Price (US$/Vial), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 83. Green Biology Recent Developments/Updates
Table 84. Green Biology Competitive Strengths & Weaknesses
Table 85. HPGC Basic Information, Manufacturing Base and Competitors
Table 86. HPGC Major Business
Table 87. HPGC Alprostadil Injection Product and Services
Table 88. HPGC Alprostadil Injection Production (Vial), Price (US$/Vial), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 89. HPGC Recent Developments/Updates
Table 90. HPGC Competitive Strengths & Weaknesses
Table 91. Swiss Parenterals Basic Information, Manufacturing Base and Competitors
Table 92. Swiss Parenterals Major Business
Table 93. Swiss Parenterals Alprostadil Injection Product and Services
Table 94. Swiss Parenterals Alprostadil Injection Production (Vial), Price (US$/Vial), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 95. Swiss Parenterals Recent Developments/Updates
Table 96. Swiss Parenterals Competitive Strengths & Weaknesses
Table 97. Endo Pharm Basic Information, Manufacturing Base and Competitors
Table 98. Endo Pharm Major Business
Table 99. Endo Pharm Alprostadil Injection Product and Services
Table 100. Endo Pharm Alprostadil Injection Production (Vial), Price (US$/Vial), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 101. Endo Pharm Recent Developments/Updates
Table 102. Endo Pharm Competitive Strengths & Weaknesses
Table 103. Ferring Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 104. Ferring Pharmaceuticals Major Business
Table 105. Ferring Pharmaceuticals Alprostadil Injection Product and Services
Table 106. Ferring Pharmaceuticals Alprostadil Injection Production (Vial), Price (US$/Vial), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 107. Ferring Pharmaceuticals Recent Developments/Updates
Table 108. Ferring Pharmaceuticals Competitive Strengths & Weaknesses
Table 109. Hikma Pharmaceuticals Basic Information, Manufacturing Base and Competitors
Table 110. Hikma Pharmaceuticals Major Business
Table 111. Hikma Pharmaceuticals Alprostadil Injection Product and Services
Table 112. Hikma Pharmaceuticals Alprostadil Injection Production (Vial), Price (US$/Vial), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 113. Hikma Pharmaceuticals Recent Developments/Updates
Table 114. Hikma Pharmaceuticals Competitive Strengths & Weaknesses
Table 115. Lifespan Biotech Basic Information, Manufacturing Base and Competitors
Table 116. Lifespan Biotech Major Business
Table 117. Lifespan Biotech Alprostadil Injection Product and Services
Table 118. Lifespan Biotech Alprostadil Injection Production (Vial), Price (US$/Vial), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 119. Lifespan Biotech Recent Developments/Updates
Table 120. Lifespan Biotech Competitive Strengths & Weaknesses
Table 121. Viatris Basic Information, Manufacturing Base and Competitors
Table 122. Viatris Major Business
Table 123. Viatris Alprostadil Injection Product and Services
Table 124. Viatris Alprostadil Injection Production (Vial), Price (US$/Vial), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 125. Viatris Recent Developments/Updates
Table 126. Viatris Competitive Strengths & Weaknesses
Table 127. Orifarm Group Basic Information, Manufacturing Base and Competitors
Table 128. Orifarm Group Major Business
Table 129. Orifarm Group Alprostadil Injection Product and Services
Table 130. Orifarm Group Alprostadil Injection Production (Vial), Price (US$/Vial), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 131. Orifarm Group Recent Developments/Updates
Table 132. Orifarm Group Competitive Strengths & Weaknesses
Table 133. Pfizer Basic Information, Manufacturing Base and Competitors
Table 134. Pfizer Major Business
Table 135. Pfizer Alprostadil Injection Product and Services
Table 136. Pfizer Alprostadil Injection Production (Vial), Price (US$/Vial), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 137. Pfizer Recent Developments/Updates
Table 138. Pfizer Competitive Strengths & Weaknesses
Table 139. Sandoz Basic Information, Manufacturing Base and Competitors
Table 140. Sandoz Major Business
Table 141. Sandoz Alprostadil Injection Product and Services
Table 142. Sandoz Alprostadil Injection Production (Vial), Price (US$/Vial), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 143. Sandoz Recent Developments/Updates
Table 144. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 145. Teva Pharmaceutical Major Business
Table 146. Teva Pharmaceutical Alprostadil Injection Product and Services
Table 147. Teva Pharmaceutical Alprostadil Injection Production (Vial), Price (US$/Vial), Production Value (USD Million), Gross Margin and Market Share (2017-2022)
Table 148. Alprostadil Injection Raw Material
Table 149. Key Manufacturers of Alprostadil Injection Raw Materials
Table 150. Alprostadil Injection Typical Distributors
Table 151. Alprostadil Injection Typical Customers

LIST OF FIGURES

Figure 1. Alprostadil Injection Picture
Figure 2. World Alprostadil Injection Production Value: 2017 & 2021 & 2028, (USD Million)
Figure 3. World Alprostadil Injection Production Value and Forecast (2017-2028) & (USD Million)
Figure 4. World Alprostadil Injection Production (2017-2028) & (Vial)
Figure 5. World Alprostadil Injection Average Price (2017-2028) & (US$/Vial)
Figure 6. World Alprostadil Injection Production Value Market Share by Region (2017-2028)
Figure 7. World Alprostadil Injection Production Market Share by Region (2017-2028)
Figure 8. North America Alprostadil Injection Production (2017-2028) & (Vial)
Figure 9. Europe Alprostadil Injection Production (2017-2028) & (Vial)
Figure 10. China Alprostadil Injection Production (2017-2028) & (Vial)
Figure 11. Japan Alprostadil Injection Production (2017-2028) & (Vial)
Figure 12. Alprostadil Injection Market Drivers
Figure 13. Factors Affecting Demand
Figure 14. World Alprostadil Injection Demand (2017-2028) & (Vial)
Figure 15. World Alprostadil Injection Consumption Market Share by Region (2017-2028)
Figure 16. United States Alprostadil Injection Consumption (2017-2028) & (Vial)
Figure 17. China Alprostadil Injection Consumption (2017-2028) & (Vial)
Figure 18. Europe Alprostadil Injection Consumption (2017-2028) & (Vial)
Figure 19. Japan Alprostadil Injection Consumption (2017-2028) & (Vial)
Figure 20. South Korea Alprostadil Injection Consumption (2017-2028) & (Vial)
Figure 21. ASEAN Alprostadil Injection Consumption (2017-2028) & (Vial)
Figure 22. India Alprostadil Injection Consumption (2017-2028) & (Vial)
Figure 23. Producer Shipments of Alprostadil Injection by Manufacturer Revenue ($MM) and Market Share (%): 2021
Figure 24. Global Four-firm Concentration Ratios (CR4) for Alprostadil Injection Markets in 2021
Figure 25. Global Four-firm Concentration Ratios (CR8) for Alprostadil Injection Markets in 2021
Figure 26. United States VS China: Alprostadil Injection Production Value Market Share Comparison (2017 & 2021 & 2028)
Figure 27. United States VS China: Alprostadil Injection Production Market Share Comparison (2017 & 2021 & 2028)
Figure 28. United States VS China: Alprostadil Injection Consumption Market Share Comparison (2017 & 2021 & 2028)
Figure 29. Key Producers and Market Share of Alprostadil Injection in United States
Figure 30. Key Producers and Market Share of Alprostadil Injection in China
Figure 31. Key Producers and Market Share of Alprostadil Injection in Rest of World
Figure 32. World Alprostadil Injection Production Value by Dosage Strength, (USD Million), 2017 & 2021 & 2028
Figure 33. World Alprostadil Injection Production Value Market Share by Dosage Strength in 2021
Figure 34. 0.5Mg/Ml
Figure 35. 1Mg/Ml
Figure 36. 2Mg/Ml
Figure 37. Other
Figure 38. World Alprostadil Injection Production Market Share by Dosage Strength (2017-2028)
Figure 39. World Alprostadil Injection Production Value Market Share by Dosage Strength (2017-2028)
Figure 40. World Alprostadil Injection Average Price by Dosage Strength (2017-2028) & (US$/Vial)
Figure 41. World Alprostadil Injection Production Value by Application, (USD Million), 2017 & 2021 & 2028
Figure 42. World Alprostadil Injection Production Value Market Share by Application in 2021
Figure 43. Myocardial Infarction
Figure 44. Thrombotic Vasculitis
Figure 45. Occlusive Arteriosclerosis
Figure 46. Other
Figure 47. World Alprostadil Injection Production Market Share by Application (2017-2028)
Figure 48. World Alprostadil Injection Production Value Market Share by Application (2017-2028)
Figure 49. World Alprostadil Injection Average Price by Application (2017-2028) & (US$/Vial)
Figure 50. Manufacturing Cost Structure Analysis of Alprostadil Injection in 2021
Figure 51. Manufacturing Process Analysis of Alprostadil Injection
Figure 52. Alprostadil Injection Industrial Chain
Figure 53. Distribution Channel Breakdown for Alprostadil Injection Shipments (%): 2017-2028
Figure 54. Direct Channel Pros & Cons
Figure 55. Indirect Channel Pros & Cons
Figure 56. Methodology
Figure 57. Research Process and Data Source


More Publications